1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. California >
  6. SomaLogic Acquires Palamedrix

M&A Deal Summary

SomaLogic Acquires Palamedrix

On July 26, 2022, SomaLogic acquired life science company Palamedrix for 35M USD

Acquisition Highlights
  • This is SomaLogic’s 1st transaction in the Life Science sector.
  • This is SomaLogic’s largest (disclosed) transaction.
  • This is SomaLogic’s 1st transaction in the United States.
  • This is SomaLogic’s 1st transaction in California.

M&A Deal Summary
Date 2022-07-26
Target Palamedrix
Sector Life Science
Buyer(s) SomaLogic
Deal Type Add-on Acquisition
Deal Value 35M USD

Target

Palamedrix

Encinitas, California, United States
Palamedrix is a developer of a multi-omic platform designed to accelerate advancements in life science and medicine. The company's platform leverages DNA nanotechnology to develop solutions for biomedical applications by providing comprehensive data, enabling doctors and patients to get an accurate and complete view of an individual's biochemistry with a single test. Palamedrix was founded in 2020 and is based in Encinitas, California.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

SomaLogic

Boulder, Colorado, United States
Category Company
Founded 2000
Sector Life Science
DESCRIPTION

SomaLogic is a data-driven proteomics technology provides health-management information. SomaLogic was founded in 2000 and is based in Boulder, Colorado.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2022 M&A 1 of 1
Size (of disclosed) 1 of 1
Mergr

Solution for

Product

Company

Legal